# PLCG2

## Overview
PLCG2 is a gene that encodes the enzyme phospholipase C gamma 2 (PLCγ2), which is a crucial component in intracellular signaling pathways. PLCγ2 is a multi-domain enzyme that functions primarily as a phospholipase, catalyzing the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to generate the second messengers inositol trisphosphate (IP3) and diacylglycerol (DAG). These messengers are vital for the regulation of calcium release and protein kinase C activation, influencing various cellular processes (Jackson2021The; Magno2021TREM2PLCγ2). The protein is characterized by several domains, including Src homology 2 (SH2) and SH3 domains, which facilitate its interactions with other proteins and its regulation through phosphorylation (Magno2021TREM2PLCγ2). PLCγ2 plays significant roles in the immune system, particularly in B cell receptor signaling and osteoclastogenesis, and is implicated in various immune dysregulation disorders when mutated (Welzel2022Variant; Mao2006PLCγ2).

## Structure
Phospholipase C gamma 2 (PLCG2) is a multi-domain enzyme involved in intracellular signaling. Its structure includes several key domains: a split pleckstrin homology (spPH) domain, two Src homology 2 (SH2) domains, an SH3 domain, and a catalytic core composed of an N-terminal PH domain, EF-hands, a TIM-like barrel, and a C2 domain (Magno2021TREM2PLCγ2). The spPH domain is crucial for interactions with Rac2, a member of the Rho family GTPases, facilitating the formation of an active signaling complex (Bunney2009Structural). The SH2 domains are essential for binding phosphotyrosine residues, while the SH3 domain interacts with poly-proline motifs, maintaining the enzyme in an autoinhibited state until activation (Magno2021TREM2PLCγ2).

The spPH domain of PLCG2 is specifically involved in the direct activation by Rac2, with the interaction being predominantly hydrophobic (Bunney2009Structural). The cSH2 domain plays a critical role in autoinhibition by interacting with the PLC-core, and mutations in this domain can lead to increased basal activity (Bunney2012Structural). Post-translational modifications, such as phosphorylation, regulate PLCG2 activity by disrupting autoinhibitory interactions, leading to enzyme activation (Bunney2012Structural). The structural arrangement of these domains allows PLCG2 to participate in complex signaling pathways, with mutations potentially leading to deregulation and disease (Liu2020Structural).

## Function
PLCG2 (phospholipase C gamma 2) is a critical enzyme involved in intracellular signal transduction, primarily through the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to generate inositol trisphosphate (IP3) and diacylglycerol (DAG). These second messengers play essential roles in regulating calcium release and protein kinase C activation, which are vital for various cellular processes (Jackson2021The; Magno2021TREM2PLCγ2).

In the adaptive immune system, PLCG2 is crucial for B cell development and function. It participates in the signal transduction cascade following B cell receptor (BCR) stimulation, associating with molecules like Syk and Btk in a lipid raft complex. This interaction leads to its phosphorylation, which is necessary for the production of IP3, DAG, and calcium flux, further activating signaling pathways such as phospholipase D and Erk (Jackson2021The).

PLCG2 also plays a significant role in osteoclastogenesis, a process essential for bone resorption. It interacts with ITAM proteins and GAB2, modulating signaling pathways crucial for osteoclast differentiation. Its catalytic activity and role as an adapter are both required for effective osteoclastogenesis, influencing RANKL signaling pathways and the activation of NF-κB and AP1 pathways (Mao2006PLCγ2).

## Clinical Significance
Mutations in the PLCG2 gene are associated with several immune dysregulation conditions, including PLCG2-associated antibody deficiency and immune dysregulation (PLAID) and autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation (APLAID). These conditions are characterized by symptoms such as cold-induced urticaria, recurrent infections, systemic inflammation, and immunodeficiency (Welzel2022Variant; Wu2021Case). 

PLAID is often linked to loss-of-function mutations, leading to antibody deficiency and increased susceptibility to infections. In contrast, APLAID is associated with gain-of-function mutations, resulting in severe autoinflammatory manifestations and antibody deficiency (Wu2021Case; MartínNalda2020Severe). 

Specific mutations, such as the hypermorphic missense mutation c.2120C>A (p.Ser707Tyr), have been identified in the PLCG2 gene. This mutation is associated with a dominantly inherited autoinflammatory disease characterized by immunodeficiency and increased PLCγ2 activity, leading to enhanced signaling pathways and inflammatory responses (Zhou2012A). 

The phenotypic overlap between PLAID and APLAID complicates diagnosis, necessitating genetic testing to confirm the presence of PLCG2 mutations (Welzel2022Variant). These conditions highlight the critical role of PLCG2 in immune regulation and the impact of its mutations on human health.

## Interactions
Phospholipase C gamma 2 (PLCγ2) is involved in various protein interactions that are crucial for its function in cellular signaling pathways. In osteoclastogenesis, PLCγ2 interacts with ITAM proteins and Gab2, playing a significant role in RANKL-induced signaling pathways. This interaction is essential for the activation of transcription factors such as NFATc1, AP1, and NF-κB, which are critical for osteoclast differentiation and bone resorption (Mao2006PLCγ2). PLCγ2 forms a complex with Gab2, which is necessary for the activation of NF-κB and JNK pathways, although not for NFATc1 (Mao2006PLCγ2).

In B cell receptor (BCR) signaling, PLCγ2 is a key effector, interacting with proteins such as Syk, BLNK, and Btk. It is recruited to the plasma membrane upon BCR crosslinking, forming a complex with phosphorylated cytoplasmic domains of the BCR, Lyn, Syk, BLNK, and Btk. The cSH2 domain of PLCγ2 is crucial for stabilizing the BCR signaling complex (Wang2014The). PLCγ2 also interacts with the BCR coreceptor CD19, forming a signaling complex with Lyn, Vav, Grb2, and p85 of PI3K (Jackson2021The). These interactions highlight the multifaceted role of PLCγ2 in immune cell activation and signal transduction.


## References


[1. (Bunney2009Structural) Tom D. Bunney, Olaniyi Opaleye, S. Mark Roe, Petra Vatter, Rhona W. Baxendale, Claudia Walliser, Katy L. Everett, Michelle B. Josephs, Carolin Christow, Fernando Rodrigues-Lima, Peter Gierschik, Laurence H. Pearl, and Matilda Katan. Structural insights into formation of an active signaling complex between rac and phospholipase c gamma 2. Molecular Cell, 34(2):223–233, April 2009. URL: http://dx.doi.org/10.1016/j.molcel.2009.02.023, doi:10.1016/j.molcel.2009.02.023. This article has 63 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.molcel.2009.02.023)

[2. (Jackson2021The) Jacob T. Jackson, Elisabeth Mulazzani, Stephen L. Nutt, and Seth L. Masters. The role of plcγ2 in immunological disorders, cancer, and neurodegeneration. Journal of Biological Chemistry, 297(2):100905, August 2021. URL: http://dx.doi.org/10.1016/j.jbc.2021.100905, doi:10.1016/j.jbc.2021.100905. This article has 47 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jbc.2021.100905)

[3. (Liu2020Structural) Yang Liu, Tom D. Bunney, Sakshi Khosa, Kévin Macé, Katharina Beckenbauer, Trevor Askwith, Sarah Maslen, Christopher Stubbs, Taiana M. de Oliveira, Kasim Sader, Mark Skehel, Anne-Claude Gavin, Christopher Phillips, and Matilda Katan. Structural insights and activating mutations in diverse pathologies define mechanisms of deregulation for phospholipase c gamma enzymes. EBioMedicine, 51:102607, January 2020. URL: http://dx.doi.org/10.1016/j.ebiom.2019.102607, doi:10.1016/j.ebiom.2019.102607. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ebiom.2019.102607)

[4. (Zhou2012A) Qing Zhou, Geun-Shik Lee, Jillian Brady, Shrimati Datta, Matilda Katan, Afzal Sheikh, Marta S. Martins, Tom D. Bunney, Brian H. Santich, Susan Moir, Douglas B. Kuhns, Debra A. Long Priel, Amanda Ombrello, Deborah Stone, Michael J. Ombrello, Javed Khan, Joshua D. Milner, Daniel L. Kastner, and Ivona Aksentijevich. A hypermorphic missense mutation in plcg2 , encoding phospholipase cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiency. The American Journal of Human Genetics, 91(4):713–720, October 2012. URL: http://dx.doi.org/10.1016/j.ajhg.2012.08.006, doi:10.1016/j.ajhg.2012.08.006. This article has 305 citations.](https://doi.org/10.1016/j.ajhg.2012.08.006)

[5. (Mao2006PLCγ2) Dailing Mao, Holly Epple, Brian Uthgenannt, Deborah V. Novack, and Roberta Faccio. Plcγ2 regulates osteoclastogenesis via its interaction with itam proteins and gab2. Journal of Clinical Investigation, 116(11):2869–2879, November 2006. URL: http://dx.doi.org/10.1172/jci28775, doi:10.1172/jci28775. This article has 184 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci28775)

[6. (Magno2021TREM2PLCγ2) Lorenza Magno, Tom D. Bunney, Emma Mead, Fredrik Svensson, and Magda N. Bictash. Trem2/plcγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation. Molecular Neurodegeneration, April 2021. URL: http://dx.doi.org/10.1186/s13024-021-00436-5, doi:10.1186/s13024-021-00436-5. This article has 32 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s13024-021-00436-5)

[7. (Wu2021Case) Na Wu, Bingqing Zhang, Tao Wang, Min Shen, and Xuejun Zeng. Case report: a rare case of autoinflammatory phospholipase cγ2 (plcγ2)-associated antibody deficiency and immune dysregulation complicated with gangrenous pyoderma and literature review. Frontiers in Immunology, May 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.667430, doi:10.3389/fimmu.2021.667430. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.667430)

[8. (MartínNalda2020Severe) Andrea Martín-Nalda, Claudia Fortuny, Lourdes Rey, Tom D. Bunney, Laia Alsina, Ana Esteve-Solé, Daniel Bull, Maria Carmen Anton, María Basagaña, Ferran Casals, Angela Deyá, Marina García-Prat, Ramon Gimeno, Manel Juan, Helios Martinez-Banaclocha, Juan J Martinez-Garcia, Anna Mensa-Vilaró, Raquel Rabionet, Nieves Martin-Begue, Francesc Rudilla, Jordi Yagüe, Xavier Estivill, Vicente García-Patos, Ramon M. Pujol, Pere Soler-Palacín, Matilda Katan, Pablo Pelegrín, Roger Colobran, Asun Vicente, and Juan I. Arostegui. Severe autoinflammatory manifestations and antibody deficiency due to novel hypermorphic plcg2 mutations. Journal of Clinical Immunology, 40(7):987–1000, July 2020. URL: http://dx.doi.org/10.1007/s10875-020-00794-7, doi:10.1007/s10875-020-00794-7. This article has 44 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10875-020-00794-7)

[9. (Welzel2022Variant) Tatjana Welzel, Lea Oefelein, Ursula Holzer, Amelie Müller, Benita Menden, Tobias B. Haack, Miriam Groβ, and Jasmin B. Kuemmerle-Deschner. Variant in the plcg2 gene may cause a phenotypic overlap of aplaid/plaid: case series and literature review. Journal of Clinical Medicine, 11(15):4369, July 2022. URL: http://dx.doi.org/10.3390/jcm11154369, doi:10.3390/jcm11154369. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jcm11154369)

[10. (Wang2014The) Jing Wang, Haewon Sohn, Guangping Sun, Joshua D. Milner, and Susan K. Pierce. The autoinhibitory c-terminal sh2 domain of phospholipase c–γ2 stabilizes b cell receptor signalosome assembly. Science Signaling, September 2014. URL: http://dx.doi.org/10.1126/scisignal.2005392, doi:10.1126/scisignal.2005392. This article has 26 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1126/scisignal.2005392)

[11. (Bunney2012Structural) Tom D. Bunney, Diego Esposito, Corine Mas-Droux, Ekatarina Lamber, Rhona W. Baxendale, Marta Martins, Ambrose Cole, Dmitri Svergun, Paul C. Driscoll, and Matilda Katan. Structural and functional integration of the plcγ interaction domains critical for regulatory mechanisms and signaling deregulation. Structure, 20(12):2062–2075, December 2012. URL: http://dx.doi.org/10.1016/j.str.2012.09.005, doi:10.1016/j.str.2012.09.005. This article has 76 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.str.2012.09.005)